Raj K. Puri
Vermogen: 1 M $ op 31-07-2026
Vermogen: 1 M $ op 31-07-2026
Dr. Raj K.
Puri is a Chief Regulatory Officer at Iovance Biotherapeutics, Inc. Dr. Puri was previously employed as a Director-Division Cellular by Center for Biologics Evaluation & Research.
He received his doctorate degree from Universidad Autónoma de Ciudad Juárez.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 248.114 ( 0,06% ) | 1 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Algemeen Adviseur | 26-11-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Universidad Autónoma de Ciudad Juárez
Universidad Autónoma de Ciudad Juárez Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau